Astellas and Theravance Announce European Marketing Authorization for VIBATIV( R ) for Nosocomial Pneumonia Caused by MRSA
Astellas and Theravance Announce European Marketing Authorization for VIBATIV( R ) for Nosocomial Pneumonia Caused by MRSA
Sep 15, 2011